JPH0215826B2 - - Google Patents
Info
- Publication number
- JPH0215826B2 JPH0215826B2 JP56044325A JP4432581A JPH0215826B2 JP H0215826 B2 JPH0215826 B2 JP H0215826B2 JP 56044325 A JP56044325 A JP 56044325A JP 4432581 A JP4432581 A JP 4432581A JP H0215826 B2 JPH0215826 B2 JP H0215826B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- alkaline phosphatase
- atom
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 claims description 39
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 36
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 36
- 239000000758 substrate Substances 0.000 claims description 30
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- -1 methylcarbonylamino group Chemical group 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 125000004436 sodium atom Chemical group 0.000 claims description 3
- 150000003014 phosphoric acid esters Chemical class 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 35
- 239000000243 solution Substances 0.000 description 28
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 239000000975 dye Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 229940126214 compound 3 Drugs 0.000 description 8
- 238000006911 enzymatic reaction Methods 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 238000004737 colorimetric analysis Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000987 azo dye Substances 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229940125797 compound 12 Drugs 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- LDKDGDIWEUUXSH-UHFFFAOYSA-N Thymophthalein Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C LDKDGDIWEUUXSH-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- VIYFPAMJCJLZKD-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate Chemical compound [Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 VIYFPAMJCJLZKD-UHFFFAOYSA-L 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- VQTGUFBGYOIUFS-UHFFFAOYSA-N nitrosylsulfuric acid Chemical compound OS(=O)(=O)ON=O VQTGUFBGYOIUFS-UHFFFAOYSA-N 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- RUYANEADGUFWRJ-UHFFFAOYSA-M sodium;(4-nitrophenyl) hydrogen phosphate Chemical compound [Na+].OP([O-])(=O)OC1=CC=C([N+]([O-])=O)C=C1 RUYANEADGUFWRJ-UHFFFAOYSA-M 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- NCPBESHYZRJICR-UHFFFAOYSA-N 1-dichlorophosphoryloxy-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(OP(Cl)(Cl)=O)C=C1 NCPBESHYZRJICR-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- ZEPAOUCWIQXIDU-UHFFFAOYSA-N 4-[(2-methylsulfonyl-4-nitrophenyl)diazenyl]phenol Chemical compound CS(=O)(=O)C1=CC([N+]([O-])=O)=CC=C1N=NC1=CC=C(O)C=C1 ZEPAOUCWIQXIDU-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- VCCIAAPOKIZVON-UHFFFAOYSA-N [4-[3-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-5-methyl-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(OP(O)(O)=O)=C(C(C)C)C=2)C)=C1C VCCIAAPOKIZVON-UHFFFAOYSA-N 0.000 description 1
- WMDDNKROYKCDJC-UHFFFAOYSA-N [4-[3-oxo-1-(4-phosphonooxyphenyl)-2-benzofuran-1-yl]phenyl] dihydrogen phosphate Chemical compound C1=CC(OP(O)(=O)O)=CC=C1C1(C=2C=CC(OP(O)(O)=O)=CC=2)C2=CC=CC=C2C(=O)O1 WMDDNKROYKCDJC-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- JFEVWPNAOCPRHQ-UHFFFAOYSA-N chembl1316021 Chemical compound OC1=CC=CC=C1N=NC1=CC=CC=C1O JFEVWPNAOCPRHQ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- WVPKAWVFTPWPDB-UHFFFAOYSA-M dichlorophosphinate Chemical compound [O-]P(Cl)(Cl)=O WVPKAWVFTPWPDB-UHFFFAOYSA-M 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without PâC bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
- C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Description
æ¬çºæã¯æ°èŠãªãªã³é
žã¢ããšã¹ãã«ã«é¢ããã
ã®ã§ãããããã«è©³ããã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢
ã¿ãŒãŒã®äœçšã«ããå æ°Žå解ãããã¢ãŸè²çŽ ãæŸ
åºããæ°èŠãªã¢ãâïŒâã¢ãªãŒã«ã¢ãŸã¢ãªãŒã«ãª
ã³é žãšã¹ãã«ã«é¢ãããã®ã§ããã 人ã®äœæ¶²äžã®ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§
ãç¥ãããšã¯èšåºæ€æ»äžæ¥µããŠéèŠã§ãããããª
ãã¡ãäžè¬ã«ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§ã
é«ãæã¯ãèèã骚çã®æ°é³ä»£è¬ãäžé ãªç¶æ ã«
ãããèèç ãããç ã骚èè «ãç²ç¶è ç°åžžãªã©
ã®çç¶ãçŸãããããšã¯ããç¥ãããŠãããåŸã€
ãŠã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§ã枬å®ããã
ãã®çš®ã ã®æ¹æ³ãèãåºãããŠããããšã¯æ¥µããŠ
åœç¶ãªããšã§ããã æ¥åžžã®èšåºæ€æ»ã«ãããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿
ãŒãŒå®éæ³ãšããŠã¯æäœãç°¡åã§ãããåçŸæ§ã®
è¯ãããšãå¿ èŠã§ãããããã®ç®çã«ã¯ãããã
æ¯è²æ³ãšã±ã€å æ³ãšãããã ããªãã¡ãæ¯è²æ³ãšã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿
ãŒãŒã®äœçšã«ãã€ãŠå æ°Žå解ãããŠè²çŽ ãããã¯
è²çŽ ã®åé§äœãæŸåºããååç©ãé µçŽ åå¿ã®åºè³ª
ãšããŠçšããé µçŽ åå¿ã®çµææŸåºãããè²çŽ ãæ¯
è²å®éããããšã«ããããããã¯é µçŽ åå¿ã®çµæ
æŸåºãããè²çŽ åé§äœããè©Šè¬ãå ããŠååŠåå¿
ãããŠè²çŽ ã«å€ãããã®è²çŽ ãæ¯è²å®éããããš
ã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§åºŠãç¥ã
æ¹æ³ã§ãããåºãæ®åããŠããæ¯è²èšãããã¯å
å å 床èšãçšããŠå®éã§ãããšããå©ç¹ãããã
äžæ¹ã±ã€å æ³ãšã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®
äœçšã«ãã€ãŠå æ°Žå解ãããŠãçºã±ã€å ç©è³ªãæŸ
åºããååç©ã®é µçŽ åå¿ã®åºè³ªãšããŠçšããé µçŽ
åå¿ã®çµææŸåºãããçºã±ã€å ç©è³ªã®ã±ã€å 匷床
ã枬å®ããããšã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒ
ã®æŽ»æ§åºŠãç¥ãæ¹æ³ã§ãããæ¯è²æ³ã«æ¯ã¹ãŠæ床
ãé«ã埮éã®å ±åããçºã±ã€å ç©è³ªã«ãã劚害ã
åããããããšããã³ã±ã€å å 床èšãããŸãæ®å
ããŠããªããšããé£ç¹ãããã æ¬çºæã¯æ¯è²æ³ã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒ
ãŒã®å®éæ³ã«ãããŠå¥œé©ãªåºè³ªãšãªãæ°èŠååç©
ã¢ããŒïŒâã¢ãªãŒã«ã¢ãŸã¢ãªãŒã«ãªã³é žãšã¹ãã«
ã«é¢ãããã®ã§ããã åŸæ¥ãæ¯è²æ³ã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒ
ã®å®éæ³ãšããŠæ¬¡ã®æ¹æ³ãçšããããŠããã (1) ïœâãããããšãã«ãªã³é žäºãããªãŠã ãåº
質ãšããŠçšããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœ
çšã«ããå æ°Žå解ã®çµææŸåºãããïœâããã
ããšããŒã«ãæ¯è²å®éããæ¹æ³ã§ãããå ·äœç
æ¹æ³ã«ã€ããŠã¯O.A.BesseyãO.H.Lowryãã
ãã³M.J.BrockèãJournal of Biological
Chemistryèªç¬¬164å·»ã321é ïŒ1946幎çºè¡ïŒã«
èšèŒãããŠããã (2) ãªã³é žããšããŒã«ãã¿ã¬ã€ã³ãåºè³ªãšããŠçš
ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ããå
æ°Žå解ã®çµææŸåºãããããšããŒã«ãã¿ã¬ã€ã³
ãæ¯è²å®éããæ¹æ³ã§ãããå ·äœçã«ã¯A.L.
BabsonãS.J.GreeleyãC.M.Colemanãããã³
G.E.PhillipsèãClinical Chemistyèªã第12
å·»ã482é ïŒ1966幎çºè¡ïŒã«èšèŒãããŠããã (3) ãªã³é žãã¢ãŒã«ãã¿ã¬ã€ã³ãåºè³ªãšããŠçš
ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ããå
æ°Žå解ã®çµææŸåºããããã¢ãŒã«ãã¿ã¬ã€ã³ã
æ¯è²å®éããæ¹æ³ã§ãããå ·äœäŸã¯C.M.
Colemann Clinal Chemistryèªã第13å·»ã401
é ïŒ1966幎çºè¡ïŒã«èšèŒãããŠããã (4) ãã¢ãŒã«ãã«ãŒã¢ããã¹ããšã€ããåºè³ªãšã
ãŠçšããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ã
ãå æ°Žå解ã®çµææŸåºããããã¢ãŒã«ãã«ãŒã
æ¯è²å®éããæ¹æ³ã§ãããå ·äœäŸã¯ç¹éæ51â
136662å·ã«èšèŒãããŠããã (5) ããšãã«ãªã³é žãåºè³ªãšããŠçšããã¢ã«ã«ãª
æ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ããå æ°Žå解ã®çµæ
æŸåºãããããšããŒã«ããèµ€è¡å¡©ã®ååšäžã§ïŒ
âã¢ããã¢ã³ãããªã³ãšé žåçž®åãããçãã
èµ€è²ããã³ãæ¯è²å®éããæ¹æ³ã§ãå ·äœäŸãšã
ãŠã¯ãP.R.N.Kindãããã³E.J.kingèã
Clinical Pathologyèªã第ïŒå·»ã322é ïŒ1954
幎çºè¡ïŒïŒæž¡èŸºè³¢èª ã»ãèããèšåºç çãèªã第
15å·»ã708é ïŒ1967幎çºè¡ãäžå±±å¹Žæ£ã»ãè
ãèšåºç çãèªã第23å·»ïŒç·äŒè£åïŒ85é
ïŒ1975幎çºè¡ïŒã«èšèŒãããŠããã 以äžã«è¿°ã¹ãåŸæ¥æ³ã®ãã¡(1)ã®æ¹æ³ã¯ã¢ã«ã«ãª
æ§ãã¹ãã¢ã¿ãŒãŒã®å®éæ³ãšããŠæãåºãçšãã
ããŠããããæ¯è²æ³¢é·ã410nïœã§ããããè¡æž
äžã®ããªã«ãã³ããã¢ã°ããã³ãªã©ã®æè²ç©ã«ã
ã劚害ãå ãããæ€äœç²æ€ãå¿ èŠãšãªããããã
ãæäœãç¹éã«ãªãæ¬ ç¹ããã€ããåŸæ¥æ³(2)ã(5)
ã®æ¹æ³ã«ãããŠã¯ãæ¯è²æ³¢é·ãããã«é·æ³¢é åã«
ãããããã®æ¬ ç¹ã¯äžå¿å æãããŠãããããã
ãªããããã¿ã¬ã€ã³é¡ã®ã¢ããªã³é žãšã¹ãã«ãåº
質ãšãã(2)ã(3)ããã³(4)ã®æ¹æ³ã«ãããŠã¯çŽåºŠã®
é«ãåºè³ªãåæããããšãé£ãããã€ãŸãããã
ãã®ã¢ããªã³é žãšã¹ãã«ã¯å¯Ÿå¿ãããã¿ã¬ã€ã³ã
ååäžã®ïŒåã®æ°Žé žåºããªãã·å¡©åãªã³ãšåå¿ã
ããŠåŸããããã¿ã¬ã€ã³ã®ã¢ããã¹ãããžã¯ããª
ããŒããå æ°Žå解ããŠåæãããããã¿ã¬ã€ã³ã«
察ãããªãã·å¡©åãªã³ã®éãå€ããšãã¿ã¬ã€ã³å
åäžã®ïŒåã®æ°Žé žåºããã¹ããªã³åãããŠããŸ
ãããŸããã¿ã¬ã€ã³ã«å¯Ÿãããªãã·å¡©åãªã³ã®é
ãå°ãªããšãªãã·å¡©åãªã³ïŒååã«å¯ŸããŠãã¿ã¬
ã€ã³ãïŒååãããã¯ïŒåååå¿ããã®ã§çæç©
ãïŒçš®ãããã¯ïŒçš®ãçæããŠããŸãããããã®
å Žåã«ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éçšåºè³ª
ãšããŠäžé©åœãªååç©ãå¯çããããããã€ãŠå
å¿åŸã®åé¢ç²Ÿè£œãç¹éã«ãªããçŽåºŠã®é«ãçæç©
ãå€ãæã«å ¥ããããšãå°é£ã§ãã€ããäžæ¹ãåŸ
æ¥æ³(5)ã®æ¹æ³ã«ãããŠã¯ããšããŒã«ãéé¢ããã
é µçŽ åå¿ãšçºè²åå¿ãšã®ïŒæ®µéã®åå¿éçšãçµã
ããšãå¿ èŠã§ããããæäœãããã ãç¹éã§ãã€
ãããã®ãã以äžã®ãããªæ¬ ç¹ã®ãªãã¢ã«ã«ãªæ§
ãã¹ãã¢ã¿ãŒãŒå®éæ³ã®åºçŸãæãŸããŠããã ãããã€ãŠãæ¬çºæã®ç®çã¯æž¬å®ã®éã®æäœæ§
ã«åªãããã€è¡äžã®è²çŽ çã®æè²ç©ã«ãã劚害ã
åãé£ããæ€åºæ床ãåªãããããåæããã³ç²Ÿ
補ã«é£ç¹ã®ãªãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒå®éçš
åºè³ªãšããŠæçšãªæ°èŠååç©åã³ãããçšããã¢
ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éæ¹æ³ãæäŸããã
ãšã§ããã äžèšã®ç®çã¯ãäžèšã®äžè¬åŒïŒïŒãŸãã¯
ïŒïŒã§ç€ºãããæ°èŠãªã¢ãâïŒâã¢ãªãŒã«ã¢ãŸ
ã¢ãªãŒã«ãªã³é žãšã¹ãã«ã«ãã€ãŠå¹æçã«éæã
ãåŸãããšãèŠåºããã ïŒåŒäžãïŒã¯æ°ŽçŽ ååããããªãŠã ååãŸãã¯ã«
ãªãŠã ååã§ãããR1ãšR2ã®äžæ¹ã¯ã¡ãã«ã¹ã«
ããã«åºãR1ãšR2ã®ä»æ¹ã¯ãããåºã§ãããR3
ã¯å¡©çŽ ååãŸãã¯æ°ŽçŽ ååãR4ã¯æ°ŽçŽ ååãã
ãããã·ã«åºãã¡ãã«åºãŸãã¯ã¡ãã«ã«ã«ããã«
ã¢ããåºã§ãããR5ã¯æ°ŽçŽ ååãŸãã¯å¡©çŽ åå
ã§ãããR6ã¯ã¡ãã«åºãŸãã¯ïŒâã¹ã«ãã¢ã¢ã€
ã«ããšãã«åºã§ãããïŒ äžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šããããååç©
ã¯ããããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ã
ã€ãŠã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§ã«æ¯äŸãã
é床ã§å æ°Žå解ãããŠå¯Ÿå¿ããã¢ãŸè²çŽ ãæŸåºã
ããããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éçšåºè³ª
ãšããŠçšããããšãã§ããã ç¹ã«äžè¬åŒïŒïŒã«ãããŠR4åã³R5ãæ°ŽçŽ å
åã§ããååç©ã¯ãåæãå ¥æãæãããŸããé µ
çŽ åå¿ã®çµææŸåºãããè²çŽ ã®å¯èŠåžåã¹ãã¯ã
ã«ã®åžå極倧波é·ã倧ãããããåååžå ä¿æ°ã
倧ããã®ã§å¥œãŸããã 次ã«ãäžèšäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šãã
ããååç©ã®å ·äœäŸã瀺ãããæ¬çºæã®ç¯å²ã¯ã
ããã®ååç©ã®ã¿ã«éå®ããããã®ã§ã¯ãªãã ååç©ïŒïŒ ååç©ïŒïŒååç©ïŒã«ãããŠNaã®ãããã«ïŒ«ãš
ãªã€ãååç© ååç©ïŒïŒ ååç©ïŒïŒååç©ïŒã«ãããŠNaã®ãããã«ïŒ«ãš
ãªã€ãååç© ååç©ïŒïŒ ååç©ïŒïŒååç©ïŒã«ãããŠNaã®ãããã«ïŒ«ãš
ãªã€ãååç© ååç©ïŒïŒ ååç©ïŒïŒ ååç©ïŒïŒ ååç©10ïŒ ååç©11ïŒ ååç©12ïŒ æ¬¡ã«äžèšäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šããã
ãååç©ã®åææ³ã«ã€ããŠè¿°ã¹ããããã§åå¿ åŒäžãã
ã®ã§ãããããã«è©³ããã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢
ã¿ãŒãŒã®äœçšã«ããå æ°Žå解ãããã¢ãŸè²çŽ ãæŸ
åºããæ°èŠãªã¢ãâïŒâã¢ãªãŒã«ã¢ãŸã¢ãªãŒã«ãª
ã³é žãšã¹ãã«ã«é¢ãããã®ã§ããã 人ã®äœæ¶²äžã®ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§
ãç¥ãããšã¯èšåºæ€æ»äžæ¥µããŠéèŠã§ãããããª
ãã¡ãäžè¬ã«ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§ã
é«ãæã¯ãèèã骚çã®æ°é³ä»£è¬ãäžé ãªç¶æ ã«
ãããèèç ãããç ã骚èè «ãç²ç¶è ç°åžžãªã©
ã®çç¶ãçŸãããããšã¯ããç¥ãããŠãããåŸã€
ãŠã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§ã枬å®ããã
ãã®çš®ã ã®æ¹æ³ãèãåºãããŠããããšã¯æ¥µããŠ
åœç¶ãªããšã§ããã æ¥åžžã®èšåºæ€æ»ã«ãããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿
ãŒãŒå®éæ³ãšããŠã¯æäœãç°¡åã§ãããåçŸæ§ã®
è¯ãããšãå¿ èŠã§ãããããã®ç®çã«ã¯ãããã
æ¯è²æ³ãšã±ã€å æ³ãšãããã ããªãã¡ãæ¯è²æ³ãšã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿
ãŒãŒã®äœçšã«ãã€ãŠå æ°Žå解ãããŠè²çŽ ãããã¯
è²çŽ ã®åé§äœãæŸåºããååç©ãé µçŽ åå¿ã®åºè³ª
ãšããŠçšããé µçŽ åå¿ã®çµææŸåºãããè²çŽ ãæ¯
è²å®éããããšã«ããããããã¯é µçŽ åå¿ã®çµæ
æŸåºãããè²çŽ åé§äœããè©Šè¬ãå ããŠååŠåå¿
ãããŠè²çŽ ã«å€ãããã®è²çŽ ãæ¯è²å®éããããš
ã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§åºŠãç¥ã
æ¹æ³ã§ãããåºãæ®åããŠããæ¯è²èšãããã¯å
å å 床èšãçšããŠå®éã§ãããšããå©ç¹ãããã
äžæ¹ã±ã€å æ³ãšã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®
äœçšã«ãã€ãŠå æ°Žå解ãããŠãçºã±ã€å ç©è³ªãæŸ
åºããååç©ã®é µçŽ åå¿ã®åºè³ªãšããŠçšããé µçŽ
åå¿ã®çµææŸåºãããçºã±ã€å ç©è³ªã®ã±ã€å 匷床
ã枬å®ããããšã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒ
ã®æŽ»æ§åºŠãç¥ãæ¹æ³ã§ãããæ¯è²æ³ã«æ¯ã¹ãŠæ床
ãé«ã埮éã®å ±åããçºã±ã€å ç©è³ªã«ãã劚害ã
åããããããšããã³ã±ã€å å 床èšãããŸãæ®å
ããŠããªããšããé£ç¹ãããã æ¬çºæã¯æ¯è²æ³ã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒ
ãŒã®å®éæ³ã«ãããŠå¥œé©ãªåºè³ªãšãªãæ°èŠååç©
ã¢ããŒïŒâã¢ãªãŒã«ã¢ãŸã¢ãªãŒã«ãªã³é žãšã¹ãã«
ã«é¢ãããã®ã§ããã åŸæ¥ãæ¯è²æ³ã«ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒ
ã®å®éæ³ãšããŠæ¬¡ã®æ¹æ³ãçšããããŠããã (1) ïœâãããããšãã«ãªã³é žäºãããªãŠã ãåº
質ãšããŠçšããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœ
çšã«ããå æ°Žå解ã®çµææŸåºãããïœâããã
ããšããŒã«ãæ¯è²å®éããæ¹æ³ã§ãããå ·äœç
æ¹æ³ã«ã€ããŠã¯O.A.BesseyãO.H.Lowryãã
ãã³M.J.BrockèãJournal of Biological
Chemistryèªç¬¬164å·»ã321é ïŒ1946幎çºè¡ïŒã«
èšèŒãããŠããã (2) ãªã³é žããšããŒã«ãã¿ã¬ã€ã³ãåºè³ªãšããŠçš
ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ããå
æ°Žå解ã®çµææŸåºãããããšããŒã«ãã¿ã¬ã€ã³
ãæ¯è²å®éããæ¹æ³ã§ãããå ·äœçã«ã¯A.L.
BabsonãS.J.GreeleyãC.M.Colemanãããã³
G.E.PhillipsèãClinical Chemistyèªã第12
å·»ã482é ïŒ1966幎çºè¡ïŒã«èšèŒãããŠããã (3) ãªã³é žãã¢ãŒã«ãã¿ã¬ã€ã³ãåºè³ªãšããŠçš
ããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ããå
æ°Žå解ã®çµææŸåºããããã¢ãŒã«ãã¿ã¬ã€ã³ã
æ¯è²å®éããæ¹æ³ã§ãããå ·äœäŸã¯C.M.
Colemann Clinal Chemistryèªã第13å·»ã401
é ïŒ1966幎çºè¡ïŒã«èšèŒãããŠããã (4) ãã¢ãŒã«ãã«ãŒã¢ããã¹ããšã€ããåºè³ªãšã
ãŠçšããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ã
ãå æ°Žå解ã®çµææŸåºããããã¢ãŒã«ãã«ãŒã
æ¯è²å®éããæ¹æ³ã§ãããå ·äœäŸã¯ç¹éæ51â
136662å·ã«èšèŒãããŠããã (5) ããšãã«ãªã³é žãåºè³ªãšããŠçšããã¢ã«ã«ãª
æ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ããå æ°Žå解ã®çµæ
æŸåºãããããšããŒã«ããèµ€è¡å¡©ã®ååšäžã§ïŒ
âã¢ããã¢ã³ãããªã³ãšé žåçž®åãããçãã
èµ€è²ããã³ãæ¯è²å®éããæ¹æ³ã§ãå ·äœäŸãšã
ãŠã¯ãP.R.N.Kindãããã³E.J.kingèã
Clinical Pathologyèªã第ïŒå·»ã322é ïŒ1954
幎çºè¡ïŒïŒæž¡èŸºè³¢èª ã»ãèããèšåºç çãèªã第
15å·»ã708é ïŒ1967幎çºè¡ãäžå±±å¹Žæ£ã»ãè
ãèšåºç çãèªã第23å·»ïŒç·äŒè£åïŒ85é
ïŒ1975幎çºè¡ïŒã«èšèŒãããŠããã 以äžã«è¿°ã¹ãåŸæ¥æ³ã®ãã¡(1)ã®æ¹æ³ã¯ã¢ã«ã«ãª
æ§ãã¹ãã¢ã¿ãŒãŒã®å®éæ³ãšããŠæãåºãçšãã
ããŠããããæ¯è²æ³¢é·ã410nïœã§ããããè¡æž
äžã®ããªã«ãã³ããã¢ã°ããã³ãªã©ã®æè²ç©ã«ã
ã劚害ãå ãããæ€äœç²æ€ãå¿ èŠãšãªããããã
ãæäœãç¹éã«ãªãæ¬ ç¹ããã€ããåŸæ¥æ³(2)ã(5)
ã®æ¹æ³ã«ãããŠã¯ãæ¯è²æ³¢é·ãããã«é·æ³¢é åã«
ãããããã®æ¬ ç¹ã¯äžå¿å æãããŠãããããã
ãªããããã¿ã¬ã€ã³é¡ã®ã¢ããªã³é žãšã¹ãã«ãåº
質ãšãã(2)ã(3)ããã³(4)ã®æ¹æ³ã«ãããŠã¯çŽåºŠã®
é«ãåºè³ªãåæããããšãé£ãããã€ãŸãããã
ãã®ã¢ããªã³é žãšã¹ãã«ã¯å¯Ÿå¿ãããã¿ã¬ã€ã³ã
ååäžã®ïŒåã®æ°Žé žåºããªãã·å¡©åãªã³ãšåå¿ã
ããŠåŸããããã¿ã¬ã€ã³ã®ã¢ããã¹ãããžã¯ããª
ããŒããå æ°Žå解ããŠåæãããããã¿ã¬ã€ã³ã«
察ãããªãã·å¡©åãªã³ã®éãå€ããšãã¿ã¬ã€ã³å
åäžã®ïŒåã®æ°Žé žåºããã¹ããªã³åãããŠããŸ
ãããŸããã¿ã¬ã€ã³ã«å¯Ÿãããªãã·å¡©åãªã³ã®é
ãå°ãªããšãªãã·å¡©åãªã³ïŒååã«å¯ŸããŠãã¿ã¬
ã€ã³ãïŒååãããã¯ïŒåååå¿ããã®ã§çæç©
ãïŒçš®ãããã¯ïŒçš®ãçæããŠããŸãããããã®
å Žåã«ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éçšåºè³ª
ãšããŠäžé©åœãªååç©ãå¯çããããããã€ãŠå
å¿åŸã®åé¢ç²Ÿè£œãç¹éã«ãªããçŽåºŠã®é«ãçæç©
ãå€ãæã«å ¥ããããšãå°é£ã§ãã€ããäžæ¹ãåŸ
æ¥æ³(5)ã®æ¹æ³ã«ãããŠã¯ããšããŒã«ãéé¢ããã
é µçŽ åå¿ãšçºè²åå¿ãšã®ïŒæ®µéã®åå¿éçšãçµã
ããšãå¿ èŠã§ããããæäœãããã ãç¹éã§ãã€
ãããã®ãã以äžã®ãããªæ¬ ç¹ã®ãªãã¢ã«ã«ãªæ§
ãã¹ãã¢ã¿ãŒãŒå®éæ³ã®åºçŸãæãŸããŠããã ãããã€ãŠãæ¬çºæã®ç®çã¯æž¬å®ã®éã®æäœæ§
ã«åªãããã€è¡äžã®è²çŽ çã®æè²ç©ã«ãã劚害ã
åãé£ããæ€åºæ床ãåªãããããåæããã³ç²Ÿ
補ã«é£ç¹ã®ãªãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒå®éçš
åºè³ªãšããŠæçšãªæ°èŠååç©åã³ãããçšããã¢
ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éæ¹æ³ãæäŸããã
ãšã§ããã äžèšã®ç®çã¯ãäžèšã®äžè¬åŒïŒïŒãŸãã¯
ïŒïŒã§ç€ºãããæ°èŠãªã¢ãâïŒâã¢ãªãŒã«ã¢ãŸ
ã¢ãªãŒã«ãªã³é žãšã¹ãã«ã«ãã€ãŠå¹æçã«éæã
ãåŸãããšãèŠåºããã ïŒåŒäžãïŒã¯æ°ŽçŽ ååããããªãŠã ååãŸãã¯ã«
ãªãŠã ååã§ãããR1ãšR2ã®äžæ¹ã¯ã¡ãã«ã¹ã«
ããã«åºãR1ãšR2ã®ä»æ¹ã¯ãããåºã§ãããR3
ã¯å¡©çŽ ååãŸãã¯æ°ŽçŽ ååãR4ã¯æ°ŽçŽ ååãã
ãããã·ã«åºãã¡ãã«åºãŸãã¯ã¡ãã«ã«ã«ããã«
ã¢ããåºã§ãããR5ã¯æ°ŽçŽ ååãŸãã¯å¡©çŽ åå
ã§ãããR6ã¯ã¡ãã«åºãŸãã¯ïŒâã¹ã«ãã¢ã¢ã€
ã«ããšãã«åºã§ãããïŒ äžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šããããååç©
ã¯ããããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®äœçšã«ã
ã€ãŠã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»æ§ã«æ¯äŸãã
é床ã§å æ°Žå解ãããŠå¯Ÿå¿ããã¢ãŸè²çŽ ãæŸåºã
ããããã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éçšåºè³ª
ãšããŠçšããããšãã§ããã ç¹ã«äžè¬åŒïŒïŒã«ãããŠR4åã³R5ãæ°ŽçŽ å
åã§ããååç©ã¯ãåæãå ¥æãæãããŸããé µ
çŽ åå¿ã®çµææŸåºãããè²çŽ ã®å¯èŠåžåã¹ãã¯ã
ã«ã®åžå極倧波é·ã倧ãããããåååžå ä¿æ°ã
倧ããã®ã§å¥œãŸããã 次ã«ãäžèšäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šãã
ããååç©ã®å ·äœäŸã瀺ãããæ¬çºæã®ç¯å²ã¯ã
ããã®ååç©ã®ã¿ã«éå®ããããã®ã§ã¯ãªãã ååç©ïŒïŒ ååç©ïŒïŒååç©ïŒã«ãããŠNaã®ãããã«ïŒ«ãš
ãªã€ãååç© ååç©ïŒïŒ ååç©ïŒïŒååç©ïŒã«ãããŠNaã®ãããã«ïŒ«ãš
ãªã€ãååç© ååç©ïŒïŒ ååç©ïŒïŒååç©ïŒã«ãããŠNaã®ãããã«ïŒ«ãš
ãªã€ãååç© ååç©ïŒïŒ ååç©ïŒïŒ ååç©ïŒïŒ ååç©10ïŒ ååç©11ïŒ ååç©12ïŒ æ¬¡ã«äžèšäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šããã
ãååç©ã®åææ³ã«ã€ããŠè¿°ã¹ããããã§åå¿ åŒäžãã
ãåŒãã®ãšãã
ã¯
ãåŒãã§ããã
ã
ãåŒãã®ãšãã
ã¯
ãåŒãã§ããã
ãŸããè³éŠæã¢ãã³ïŒ¡âNH2ïŒïŒãšããšããŒ
ã«èªå°äœïŒšââOHãšãåžžæ³ã«ãããžã¢ãŸã«ã
ããªã³ã°ãããŠã¢ãŸè²çŽ ïŒïŒ¡âïŒïŒ®ââ
OHïŒïŒïŒãåæããããªããã«åŒ·ãé»ååž
åŒæ§åºã§ããã¡ãã«ã¹ã«ããã«åºãšãããåºãå
åšããããããžã¢ãŸåã«ãã€ãŠçãããžã¢ãŸããŠ
ã å¡©ãåæããã«ããã€ãŠã¯ãããããããã·ã«
ç¡«é žæ³ïŒããšãã°S.R.Sandlerããã³W.karoè
ãOrganic Functional Group Preparationsã第
ïŒå·»ã295é ïŒ1971幎Academic Pressçºè¡ïŒã«
å ·äœäŸãèšèŒãããŠãããïŒãçšããããšã奜ãŸ
ããã âNH2 ïŒïŒãžã¢ãŸå âââââ âN2 + ââOH âââââââ âïŒïŒ®ââOH ïŒïŒ 次ãã§ããªãžã³ã®ååšäžã«ã¢ãŸè²çŽ ïŒïŒã倧
éå°ã®ãªãã·å¡©åãªã³ãšåå¿ãããŠãã¹ãããžã¯
ããªããŒãïŒïŒ¶ïŒãšããåŸãïŒïŒ¶ïŒãæ°Žãšåå¿ã
ããŠãªã³é žã¢ããšã¹ãã«ïŒIâ²ïŒãšããã ïŒïŒããïŒïŒãåŸãåå¿ã«ãããŠã¯ãïŒïŒ
ã®ïŒåã¢ã«ä»¥äžã奜ãŸããã¯ïŒåãªãã10åã¢ã«
ã®ãªãã·å¡©åãªã³ãã¢ã»ãã³ãããªã¡ãã«ãªã³é ž
ãããã¯ã¢ã»ãã³ãšããªã¡ãã«ãªã³é žãšã®æ··å溶
åªã«ãŠïŒãªãã50åã奜ãŸããã¯ïŒã10åã«åžé
ãã溶液ã«â15âãªãã10âã奜ãŸããã¯â10â
ãªããïŒâã§ãïŒïŒãããªãžã³ãããªãžã³ãå«
ãã¢ã»ãã³ãããªãžã³ãå«ãããªã¡ãã«ãªã³é žã
ãããã¯ããªãžã³ãå«ãã¢ã»ãã³ãšããªã¡ãã«ãª
ã³é žãšã®æ··å溶åªã«æº¶ããã溶液ã滎äžããããš
ã«ãããã»ãšãã©å¯çæç©ãçããããšãªã
ïŒïŒãïŒïŒãžå€æããããšãã§ããããšãèŠ
åºããããªãããªãžã³ã®ä»£ãã«ãããªãšãã«ã¢ã
ã³çã®ããªãžã³ããå¡©åºæ§ã®åŒ·ãïŒçŽã¢ãã³
ïŒïŒã®æº¶æ¶²ã«å ããŠãããã€ãããªããïŒïŒã®
çæã¯ã·ãªã«ã²ã«èå±€ã¯ãããã°ã©ãã€ãŒã«ãã
ãŠïŒïŒãããRfå€ã®å°ããã¹ããããåºçŸã
ãããšã«ãã€ãŠç¢ºèªã§ãããåŸæ¥ããšãã°ïœâã
ããããšãã«ãã¹ãããžã¯ããªããŒãã®ããšãã¢
ãªãŒã«ãã¹ãããžã¯ããªããŒãã¯ãªãã·å¡©åãªã³
ãšããšããŒã«ãšãå¡©åã«ãªãŠã ãªã©ã®ååšäžã«å
ç±éæµããããšã«ããåæãããŠããã ãã®å ·äœäŸã¯ãããšãã°åå±±ããã³æ©æ¬èã
Bulletin of the Chemical Society of Japan
èªã第44å·»ã196é ïŒ1971幎çºè¡ïŒã«èšèŒãããŠ
ããã ããããã®ãããªæ¿ããæ¡ä»¶äžã§ã¯ãäžèšåå
ç©ïŒïŒã¯å¹çããçæããªãã€ãã ïŒïŒãïŒIâ²ïŒãžäº€æããéã«ã¯ãïŒïŒãå
é¢ããã«åå¿æ¶²ã«æ°Žãå ããã°ããããã ãé žæ§
æ¡ä»¶äžã§ã¯ïŒIâ²ïŒãå解ããããšããããã
ïŒïŒãšæ°Žãšã®åå¿ã«éããŠã¯çºçããå¡©åæ°ŽçŽ
ãææãåŸãããªãžã³çã®äžçŽã¢ãã³ãå ããã
é ¢é žãšãã«ãªã©ã®æ°Žã«äžæº¶ãªæº¶åªãå ±åãããŠæ°Ž
âæ²¹ã®ïŒå±€ç³»ãšããããšã«ãã€ãŠå¥œãŸããçµæã
åŸãããããšãããã ããããŠåŸãïŒIâ²ïŒã«æ¿ãæ°Žé žåãããªãŠã ã
ããã¯æ°Žé žåã«ãªãŠã ã®æ°Žæº¶æ¶²ãå ããŠæº¶è§£ãPH
ãçŽ10ã«èª¿ç¯ããåŸäžæº¶éšãæ¿Ÿå»ããŠåŸã溶液ã
ãã®çŽ10ã20å容ã®ãšã¿ããŒã«äžã«æ¹æãã€ã€æ»Ž
äžããããšã«ãã€ãŠïŒïŒãŸãã¯ïŒïŒã®çµæ¶ã
åŸãããšãã§ããã ããããŠåŸãååç©ïŒïŒãŸãã¯ïŒïŒãå°é
ã®æ°Žã®æº¶ãããåŸããšã¿ããŒã«äžã«æ³šå ¥ããŠæ¶æ
ããããšã«ãã粟補ãè¡ãªãããšãã§ããã ãªããã®æ¹æ³ã«ãã€ãŠåŸãçµæ¶ã«ã¯ãïŒååã
ããæ°ååã®çµæ¶æ°Žãå«ãããšãå€ãã 以äžã®ããã«ããŠåæããäžèšäžè¬åŒïŒïŒãŸ
ãã¯ïŒïŒã§è¡šããããæ¬çºæã®ååç©ã¯ã¢ã«ã«
ãªæ§ãã¹ãã¢ã¿ãŒãŒå®éçšåºè³ªãšããŠåªããŠã
ããããªãã¡äžèšäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡š
ããããååç©ã¯ã(1)ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒ
ã®äœçšã«ãã€ãŠãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»
æ§åºŠã«æ¯äŸããé床ãŠå æ°Žå解ãããŠã¢ãŸããšã
ãŒã«è²çŽ ãäžãã(2)ãããã®è²çŽ ã¯ãåŸæ¥åºãè¡
ãªãããŠããïœâãããããšãã«ãªã³é žãããªãŠ
ã ãåºè³ªãšããŠçšããæ¹æ³ã«ãããåè²è²çŽ ã§ã
ãïœâãããããšããŒã«ãããé·æ³¢é·åŽã«å¯èŠå
åžå極倧ãæããã®ã§ãããã ãè¡äžè²çŽ çã®æ
è²ç©è³ªã«ãã劚害ãåãé£ãã(3)ãã€ãããã®è²
çŽ ã¯æ°Žæº¶æ§ã§ãããããé µçŽ æŽ»æ§æž¬å®äžã«åéã
æ²æŸ±ãèµ·ããããšããªãããããã€ãŠã¢ã«ã«ãªæ§
ãã¹ãã¢ã¿ãŒãŒå®éçšåºè³ªãšããŠäœ¿çšããå Žåã
å®éè©Šéšæ¡ä»¶èšå®ã®èªç±åºŠãé«ãã(4)ãããåæ
äŸã«ç€ºãéãåæã«é£ç¹ããªããæ¬æ现æžã®åé
ã«è¿°ã¹ããšãããªã³é žãã¿ã¬ã€ã³ããªã³é žãã¢ãŒ
ã«ãã¿ã¬ã€ã³ããããã¯ãã¢ãŒã«ãã«ãŒã¢ããã¹
ããšã€ãã®åæã«ãããŠã¯ååç©ã®åé¢ç²Ÿè£œæäœ
ãç¹éã§ããã®ãšã¯å¯Ÿç §çã«ãéåžžã®æ¶æã«ãã€
ãŠç²Ÿè£œã§ããã æ¬çºæã®ååç©ãçšããŠã¢ã«ã«ãªæ§ãã¹ãã¢ã¿
ãŒãŒãå®éããã«ã¯ãBesseyâLowryæ³
ïŒJournal of Biological Chemistryèªã第164å·»ã
321é ã1946幎çºè¡ã«èšèŒãããŠãããïŒã«ããã
ïœâãããããšãã«ãªã³é žäºãããªãŠã ã®ããã
ã«æ¬çºæã®ååç©ãçšããBesseyâLowryæ³ã«
ãããŠé µçŽ åå¿ã®çµæçããïœâãããããšããŒ
ã«ã®éãæ±ãããããã«æ¬çºæã®ååç©ããçã
ãã¢ãŸè²çŽ âïŒïŒ®ââOHã®éãæ±ããã°
ããã äŸãã°ããŸããäžè¬åŒïŒïŒãŸãã¯ïŒïŒã«ãŠ
瀺ãããååç©ãPH10ååŸã®ç·©è¡æ¶²ã«æº¶è§£ãåºè³ª
液ã調補ããããã®ãšããåºè³ªæ¶²ã«ãé µçŽ æŽ»æ§å
å€ïŒäŸãã°å¡©åãã°ãã·ãŠã ïŒãªã©ãæ·»å ãããš
奜ãŸããã次ã«ããã®åºè³ªæ¶²ã«ã被枬å®ç©ã§ãã
ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒãå«æãã液ãæ·»å ã
åå¿ãè¡ãªããããããã®ãšããäžè¬åŒïŒïŒãŸ
ãã¯ïŒïŒã§ç€ºãããååç©ã¯ãåºè³ªæ¶²äžã«ãïŒ
ã20ããªã¢ã«ïŒã®æ¿åºŠã§ååšããŠããã®ã奜ãŸ
ããã ãŸããäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§ç€ºãããå
åç©ã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã«å¯ŸããŠã倧
éå°ã«ãããªãã¡ã¢ã«æ¯ã§ã¯10å以äžååšããŠã
ãããšã奜ãŸãããäžèšåå¿ã¯ã10ã50âãã奜
ãŸããã¯30ã40âã®æž©åºŠã«ãŠã10ã60åéã®æé
ã«ãŠè¡ãªãããã次ã«ãå¿ èŠã«å¿ããŠã溶液ã®PH
ãå¡©åºãŸãã¯é žãæ·»å ããŠäžããããäžãããã
å Žåã«ãã€ãŠã¯ãDMFïŒãžã¡ãã«ãã«ã ã¢ã«ãïŒã
ã¡ãã«ã»ããœã«ãçã®ææ©æº¶å€ãæ·»å ããŠãã®å
å¿ãåæ¢ãããã®ãšãã®çæããã¢ãŸè²çŽ ã®æ¿åºŠ
ãåå å 床èšãªã©ã«ãã€ãŠæ¿åºŠæž¬å®ããããšã«ã
ã€ãŠãå¿ èŠã«ãããæ€éç·ããã¢ã«ã«ãªæ§ãã¹ã
ã¢ã¿ãŒãŒãå®éããã æ¯è²æ³¢é·ã¯åœè©²è²çŽ ã®åžå極倧波é·ä»è¿ã«èšå®
ããã°ããããæ¯è²ã®éã«ã·ã¯ãããã¹ããªã³é¡
奜ãŸããã¯Î±âã·ã¯ãããã¹ããªã³ãæ·»å ããã
ãšã«ããåžå極倧波é·ãé·æ³¢åŽãžã·ãããããã
ãšãå¯èœã§ããã ãã®ãšããã·ã¯ãããã¹ããªã³é¡ã®æ·»å éã¯ã
æ¯è²æ¶²ïŒmlåœã0.1mgãªãã20mgãªããã奜ãŸã
ãã¯ïŒmgãªãã10mgã§ããã 次ã«ãæ¬çºæã®äžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡š
ããããååç©ã®ãã¡ä»£è¡šçãªãã®ã«ã€ããŠåæ
äŸã瀺ããäžèšã®ååç©ä»¥å€ã®ãã®ã«ã€ããŠãå
è¿°ã®åææ³ã«åºã¥ãããŸãäžèšã®èšèŒã«é ããŠå®¹
æã«åæããããšãã§ããã åæäŸïŒååç©ïŒã®åæ ãªãã·å¡©åãªã³ïŒmlãšã¢ã»ãã³20mlãšãæ··åã
âïŒâã«å·åŽããããã®æº¶æ¶²ã«ãïŒâïŒïŒâã¡ã¿
ã³ã¹ã«ããã«âïŒâãããããšãã«ã¢ãŸïŒããšã
ãŒã«ïŒïœãã¢ã»ãã³20mlãããªã¡ãã«ãªã³é ž10
mlãããªãžã³ïŒmlãããã³ããªãšãã«ã¢ãã³0.5
mlã«æº¶ããã溶液ã25åéã«ããã€ãŠæ»Žäžããã
ãã®éãåå¿æ¶²ã®æž©åºŠãïŒâãè¶ãã¬ããã«å€éš
ããå·åŽãããããã«30åéïŒâ以äžã§æ¹æãç¶
ããåŸã30mlã®æ°Žã滎äžããã宀枩ã§10åéæ¹æ
ããåŸã200mlã®é£œåé£å¡©æ°Žãšæ°·ãšã®æ··åç©äžã«
æ³šå ¥ããçããçµæ¶ãæ¿Ÿåããããã®çµæ¶ã«ïŒèŠ
å®ã®æ°Žé žåãããªãŠã 氎溶液20mlãå ãPHãçŽ10
ãšãããäžæº¶éšãæ¿ŸåŽããåŸã濟液ããšã¿ããŒã«
150mläžã«æ³šå ¥ããçããçµæ¶ãæ¿Ÿåããšã¿ããŒ
ã«ã§æŽæµããæžå§äžã«ä¹Ÿç¥ããã åéïŒïœãλ0.02N-NaOH nax382nïœ æ¬¡ã«ãæ¬çºæã«ã€ããŠã代衚çãªååç©ã«ã€ã
ãŠãå®æœäŸã«åºã¥ãå ·äœçã«èª¬æãããããããª
ãããæ¬çºæã¯ãäžèšã®å®æœäŸã«ã®ã¿éå®ããã
ãã®ã§ã¯ãªãã å®æœäŸ ïŒ åºè³ªæ¶²ã®èª¿è£œïŒååç©ïŒã®çµæ¶35.05mgã10ml
ã®ã°ãªã·ã³ç·©è¡æ¶²ïŒPH10ã0.5mmolïŒã®å¡©åã
ã°ãã·ãŠã ãå«ãïŒã«æº¶ãããã é µçŽ æ¶²ã®èª¿è£œïŒã·ã°ãã±ãã«ã«ç€Ÿã¢ã«ã«ãªæ§ã
ã¹ãã¢ã¿ãŒãŒTypeIçŽïŒmgã20mlã®èžçæ°Žã«æº¶ã
ãã液ããã³ããã®æ¶²ãïŒåããã³ïŒåã«åžéã
ã液ãïŒçš®é¡èª¿è£œããã æäœïŒåºè³ªæ¶²ïŒmlãè©Šéšç®¡ã«å ¥ã37âã«ïŒåé
å æž©ãããé µçŽ æ¶²0.1mlãå ãã37âã§30åéå
æž©ãåå¿ãããåŸ0.02èŠå®ã®æ°Žé žåãããªãŠã æ°Ž
溶液10mlãå ããŠåå¿ãåæ¢ãããé µçŽ æ¶²ã®ãã
ãã«èžçæ°Žãçšããç¹ãé€ããŠå šãåæ§ã«åŠçã
ãç²æ€æ¶²ãå¯Ÿç §ãšããŠ520nïœã§åžå 床ïŒÎODïŒ
ã枬å®ããããã®ããã«ããŠãæ¿åºŠã®ç°ãªã€ãïŒ
çš®é¡ã®é µçŽ 液ã«ã€ããŠåã 枬å®ãè¡ãªã€ãããã
ããšåãé µçŽ æ¶²ã«ã€ããŠBesseyâLowryæ³ãé©
çšããå Žåã®410nïœã«ãããç²æ€æ¶²ãå¯Ÿç §ãšã
ãåžå 床ïŒÎODïŒã枬å®ããã ãªãBesseyâLowryæ³ã®æäœã¯äžèšååç©ïŒ
ã®çµæ¶35.05mgã®ãããã«ïœâãããããšãã«ãª
ã³é žãããªãŠã 20mgãçšããŠ410nïœã§æ¯è²ãã
ä»ã¯äžèšã®æäœãšå šãåæ§ã§ããã ãããïŒã€ã®æ¹æ³ã«ããÎODã®å€ã®é¢ä¿ã第
ïŒå³ã«ç€ºããã ãã®ç¬¬ïŒå³ãã次ã®ããšãæãããšãªã€ãã (1) é µçŽ æ¿åºŠã«æ¯äŸããŠãããªãã¡Besseyâ
Lowryæ³ã«ããå€ã«æ¯äŸããŠÎODãå€åãã
ã®ã§ÎODã®å€ããé µçŽ ã®æŽ»æ§ãæ±ããããšã
ã§ããã (2) ååç©ïŒãåºè³ªãšããå Žåã®ÎODã¯Bessey
âLowryæ³ã®â³ODãã倧ããªå²åã§å€åããŠ
ããã®ã§ïŒçŽç·ã®åŸé ãïŒä»¥äžïŒãååç©ïŒã
åºè³ªãšããå Žåã®ã»ããBesseyâLowryæ³ã
ãæ床ãé«ãã (3) ååç©ïŒãåºè³ªãšããå Žåã«ã¯520nïœã§æ¯
è²ã§ããã®ã§ã410nïœã§æ¯è²ããBesseyâ
Lowryæ³ãããè¡äžã®è²çŽ ãªã©ã®æè²ç©è³ªã«
ãã劚害ãåãé£ãã ãã®ããã«æ¬çºæã®ååç©ã¯ãã¢ã«ã«ãªæ§ãã¹
ãã¢ã¿ãŒãŒã®å®éçšåºè³ªãšããŠå¥œé©ãªååç©ã§ã
ãããšããããã å®æœäŸ ïŒ å®æœäŸïŒã®ååç©ïŒã®çµæ¶35.05mgã®ãããã«
48.18mgã®ååç©12ã®çµæ¶ãçšããåžå 床ã®æž¬å®
ã520nïœã§ã¯ãªã644nïœã§è¡ãªãä»ã¯å®æœäŸïŒ
ãšåæ§ã®æäœãè¡ãªã€ãå Žåã®çµæã第ïŒå³ã«ç€º
ããããã®ç¬¬ïŒå³ãã次ã®ããšãæããã§ããã (1) é µçŽ æ¿åºŠã«æ¯äŸããŠãããªãã¡Besseyâ
Lowryæ³ã«ããå€ã«æ¯äŸããŠÎODãå€åãã
ã®ã§ÎODã®å€ããé µçŽ ã®æŽ»æ§ãæ±ããããšã
ã§ããã (2) ååç©12ãåºè³ªãšããå Žåã«ã¯644nïœã§æ¯
è²ã§ããã®ã§ã410nïœã§æ¯è²ããBesseyâ
Lowryæ³ããè¡äžã®è²çŽ ãªã©ã®æè²ç©è³ªã«åŠš
害ãåãé£ãã ãã®ããã«æ¬çºæã®ååç©ã¯ãã¢ã«ã«ãªæ§ãã¹
ãã¢ã¿ãŒãŒã®å®éçšåºè³ªãšããŠå¥œé©ãªååç©ã§ã
ãããšããããã
ã«èªå°äœïŒšââOHãšãåžžæ³ã«ãããžã¢ãŸã«ã
ããªã³ã°ãããŠã¢ãŸè²çŽ ïŒïŒ¡âïŒïŒ®ââ
OHïŒïŒïŒãåæããããªããã«åŒ·ãé»ååž
åŒæ§åºã§ããã¡ãã«ã¹ã«ããã«åºãšãããåºãå
åšããããããžã¢ãŸåã«ãã€ãŠçãããžã¢ãŸããŠ
ã å¡©ãåæããã«ããã€ãŠã¯ãããããããã·ã«
ç¡«é žæ³ïŒããšãã°S.R.Sandlerããã³W.karoè
ãOrganic Functional Group Preparationsã第
ïŒå·»ã295é ïŒ1971幎Academic Pressçºè¡ïŒã«
å ·äœäŸãèšèŒãããŠãããïŒãçšããããšã奜ãŸ
ããã âNH2 ïŒïŒãžã¢ãŸå âââââ âN2 + ââOH âââââââ âïŒïŒ®ââOH ïŒïŒ 次ãã§ããªãžã³ã®ååšäžã«ã¢ãŸè²çŽ ïŒïŒã倧
éå°ã®ãªãã·å¡©åãªã³ãšåå¿ãããŠãã¹ãããžã¯
ããªããŒãïŒïŒ¶ïŒãšããåŸãïŒïŒ¶ïŒãæ°Žãšåå¿ã
ããŠãªã³é žã¢ããšã¹ãã«ïŒIâ²ïŒãšããã ïŒïŒããïŒïŒãåŸãåå¿ã«ãããŠã¯ãïŒïŒ
ã®ïŒåã¢ã«ä»¥äžã奜ãŸããã¯ïŒåãªãã10åã¢ã«
ã®ãªãã·å¡©åãªã³ãã¢ã»ãã³ãããªã¡ãã«ãªã³é ž
ãããã¯ã¢ã»ãã³ãšããªã¡ãã«ãªã³é žãšã®æ··å溶
åªã«ãŠïŒãªãã50åã奜ãŸããã¯ïŒã10åã«åžé
ãã溶液ã«â15âãªãã10âã奜ãŸããã¯â10â
ãªããïŒâã§ãïŒïŒãããªãžã³ãããªãžã³ãå«
ãã¢ã»ãã³ãããªãžã³ãå«ãããªã¡ãã«ãªã³é žã
ãããã¯ããªãžã³ãå«ãã¢ã»ãã³ãšããªã¡ãã«ãª
ã³é žãšã®æ··å溶åªã«æº¶ããã溶液ã滎äžããããš
ã«ãããã»ãšãã©å¯çæç©ãçããããšãªã
ïŒïŒãïŒïŒãžå€æããããšãã§ããããšãèŠ
åºããããªãããªãžã³ã®ä»£ãã«ãããªãšãã«ã¢ã
ã³çã®ããªãžã³ããå¡©åºæ§ã®åŒ·ãïŒçŽã¢ãã³
ïŒïŒã®æº¶æ¶²ã«å ããŠãããã€ãããªããïŒïŒã®
çæã¯ã·ãªã«ã²ã«èå±€ã¯ãããã°ã©ãã€ãŒã«ãã
ãŠïŒïŒãããRfå€ã®å°ããã¹ããããåºçŸã
ãããšã«ãã€ãŠç¢ºèªã§ãããåŸæ¥ããšãã°ïœâã
ããããšãã«ãã¹ãããžã¯ããªããŒãã®ããšãã¢
ãªãŒã«ãã¹ãããžã¯ããªããŒãã¯ãªãã·å¡©åãªã³
ãšããšããŒã«ãšãå¡©åã«ãªãŠã ãªã©ã®ååšäžã«å
ç±éæµããããšã«ããåæãããŠããã ãã®å ·äœäŸã¯ãããšãã°åå±±ããã³æ©æ¬èã
Bulletin of the Chemical Society of Japan
èªã第44å·»ã196é ïŒ1971幎çºè¡ïŒã«èšèŒãããŠ
ããã ããããã®ãããªæ¿ããæ¡ä»¶äžã§ã¯ãäžèšåå
ç©ïŒïŒã¯å¹çããçæããªãã€ãã ïŒïŒãïŒIâ²ïŒãžäº€æããéã«ã¯ãïŒïŒãå
é¢ããã«åå¿æ¶²ã«æ°Žãå ããã°ããããã ãé žæ§
æ¡ä»¶äžã§ã¯ïŒIâ²ïŒãå解ããããšããããã
ïŒïŒãšæ°Žãšã®åå¿ã«éããŠã¯çºçããå¡©åæ°ŽçŽ
ãææãåŸãããªãžã³çã®äžçŽã¢ãã³ãå ããã
é ¢é žãšãã«ãªã©ã®æ°Žã«äžæº¶ãªæº¶åªãå ±åãããŠæ°Ž
âæ²¹ã®ïŒå±€ç³»ãšããããšã«ãã€ãŠå¥œãŸããçµæã
åŸãããããšãããã ããããŠåŸãïŒIâ²ïŒã«æ¿ãæ°Žé žåãããªãŠã ã
ããã¯æ°Žé žåã«ãªãŠã ã®æ°Žæº¶æ¶²ãå ããŠæº¶è§£ãPH
ãçŽ10ã«èª¿ç¯ããåŸäžæº¶éšãæ¿Ÿå»ããŠåŸã溶液ã
ãã®çŽ10ã20å容ã®ãšã¿ããŒã«äžã«æ¹æãã€ã€æ»Ž
äžããããšã«ãã€ãŠïŒïŒãŸãã¯ïŒïŒã®çµæ¶ã
åŸãããšãã§ããã ããããŠåŸãååç©ïŒïŒãŸãã¯ïŒïŒãå°é
ã®æ°Žã®æº¶ãããåŸããšã¿ããŒã«äžã«æ³šå ¥ããŠæ¶æ
ããããšã«ãã粟補ãè¡ãªãããšãã§ããã ãªããã®æ¹æ³ã«ãã€ãŠåŸãçµæ¶ã«ã¯ãïŒååã
ããæ°ååã®çµæ¶æ°Žãå«ãããšãå€ãã 以äžã®ããã«ããŠåæããäžèšäžè¬åŒïŒïŒãŸ
ãã¯ïŒïŒã§è¡šããããæ¬çºæã®ååç©ã¯ã¢ã«ã«
ãªæ§ãã¹ãã¢ã¿ãŒãŒå®éçšåºè³ªãšããŠåªããŠã
ããããªãã¡äžèšäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡š
ããããååç©ã¯ã(1)ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒ
ã®äœçšã«ãã€ãŠãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®æŽ»
æ§åºŠã«æ¯äŸããé床ãŠå æ°Žå解ãããŠã¢ãŸããšã
ãŒã«è²çŽ ãäžãã(2)ãããã®è²çŽ ã¯ãåŸæ¥åºãè¡
ãªãããŠããïœâãããããšãã«ãªã³é žãããªãŠ
ã ãåºè³ªãšããŠçšããæ¹æ³ã«ãããåè²è²çŽ ã§ã
ãïœâãããããšããŒã«ãããé·æ³¢é·åŽã«å¯èŠå
åžå極倧ãæããã®ã§ãããã ãè¡äžè²çŽ çã®æ
è²ç©è³ªã«ãã劚害ãåãé£ãã(3)ãã€ãããã®è²
çŽ ã¯æ°Žæº¶æ§ã§ãããããé µçŽ æŽ»æ§æž¬å®äžã«åéã
æ²æŸ±ãèµ·ããããšããªãããããã€ãŠã¢ã«ã«ãªæ§
ãã¹ãã¢ã¿ãŒãŒå®éçšåºè³ªãšããŠäœ¿çšããå Žåã
å®éè©Šéšæ¡ä»¶èšå®ã®èªç±åºŠãé«ãã(4)ãããåæ
äŸã«ç€ºãéãåæã«é£ç¹ããªããæ¬æ现æžã®åé
ã«è¿°ã¹ããšãããªã³é žãã¿ã¬ã€ã³ããªã³é žãã¢ãŒ
ã«ãã¿ã¬ã€ã³ããããã¯ãã¢ãŒã«ãã«ãŒã¢ããã¹
ããšã€ãã®åæã«ãããŠã¯ååç©ã®åé¢ç²Ÿè£œæäœ
ãç¹éã§ããã®ãšã¯å¯Ÿç §çã«ãéåžžã®æ¶æã«ãã€
ãŠç²Ÿè£œã§ããã æ¬çºæã®ååç©ãçšããŠã¢ã«ã«ãªæ§ãã¹ãã¢ã¿
ãŒãŒãå®éããã«ã¯ãBesseyâLowryæ³
ïŒJournal of Biological Chemistryèªã第164å·»ã
321é ã1946幎çºè¡ã«èšèŒãããŠãããïŒã«ããã
ïœâãããããšãã«ãªã³é žäºãããªãŠã ã®ããã
ã«æ¬çºæã®ååç©ãçšããBesseyâLowryæ³ã«
ãããŠé µçŽ åå¿ã®çµæçããïœâãããããšããŒ
ã«ã®éãæ±ãããããã«æ¬çºæã®ååç©ããçã
ãã¢ãŸè²çŽ âïŒïŒ®ââOHã®éãæ±ããã°
ããã äŸãã°ããŸããäžè¬åŒïŒïŒãŸãã¯ïŒïŒã«ãŠ
瀺ãããååç©ãPH10ååŸã®ç·©è¡æ¶²ã«æº¶è§£ãåºè³ª
液ã調補ããããã®ãšããåºè³ªæ¶²ã«ãé µçŽ æŽ»æ§å
å€ïŒäŸãã°å¡©åãã°ãã·ãŠã ïŒãªã©ãæ·»å ãããš
奜ãŸããã次ã«ããã®åºè³ªæ¶²ã«ã被枬å®ç©ã§ãã
ã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒãå«æãã液ãæ·»å ã
åå¿ãè¡ãªããããããã®ãšããäžè¬åŒïŒïŒãŸ
ãã¯ïŒïŒã§ç€ºãããååç©ã¯ãåºè³ªæ¶²äžã«ãïŒ
ã20ããªã¢ã«ïŒã®æ¿åºŠã§ååšããŠããã®ã奜ãŸ
ããã ãŸããäžè¬åŒïŒïŒãŸãã¯ïŒïŒã§ç€ºãããå
åç©ã¯ãã¢ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã«å¯ŸããŠã倧
éå°ã«ãããªãã¡ã¢ã«æ¯ã§ã¯10å以äžååšããŠã
ãããšã奜ãŸãããäžèšåå¿ã¯ã10ã50âãã奜
ãŸããã¯30ã40âã®æž©åºŠã«ãŠã10ã60åéã®æé
ã«ãŠè¡ãªãããã次ã«ãå¿ èŠã«å¿ããŠã溶液ã®PH
ãå¡©åºãŸãã¯é žãæ·»å ããŠäžããããäžãããã
å Žåã«ãã€ãŠã¯ãDMFïŒãžã¡ãã«ãã«ã ã¢ã«ãïŒã
ã¡ãã«ã»ããœã«ãçã®ææ©æº¶å€ãæ·»å ããŠãã®å
å¿ãåæ¢ãããã®ãšãã®çæããã¢ãŸè²çŽ ã®æ¿åºŠ
ãåå å 床èšãªã©ã«ãã€ãŠæ¿åºŠæž¬å®ããããšã«ã
ã€ãŠãå¿ èŠã«ãããæ€éç·ããã¢ã«ã«ãªæ§ãã¹ã
ã¢ã¿ãŒãŒãå®éããã æ¯è²æ³¢é·ã¯åœè©²è²çŽ ã®åžå極倧波é·ä»è¿ã«èšå®
ããã°ããããæ¯è²ã®éã«ã·ã¯ãããã¹ããªã³é¡
奜ãŸããã¯Î±âã·ã¯ãããã¹ããªã³ãæ·»å ããã
ãšã«ããåžå極倧波é·ãé·æ³¢åŽãžã·ãããããã
ãšãå¯èœã§ããã ãã®ãšããã·ã¯ãããã¹ããªã³é¡ã®æ·»å éã¯ã
æ¯è²æ¶²ïŒmlåœã0.1mgãªãã20mgãªããã奜ãŸã
ãã¯ïŒmgãªãã10mgã§ããã 次ã«ãæ¬çºæã®äžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡š
ããããååç©ã®ãã¡ä»£è¡šçãªãã®ã«ã€ããŠåæ
äŸã瀺ããäžèšã®ååç©ä»¥å€ã®ãã®ã«ã€ããŠãå
è¿°ã®åææ³ã«åºã¥ãããŸãäžèšã®èšèŒã«é ããŠå®¹
æã«åæããããšãã§ããã åæäŸïŒååç©ïŒã®åæ ãªãã·å¡©åãªã³ïŒmlãšã¢ã»ãã³20mlãšãæ··åã
âïŒâã«å·åŽããããã®æº¶æ¶²ã«ãïŒâïŒïŒâã¡ã¿
ã³ã¹ã«ããã«âïŒâãããããšãã«ã¢ãŸïŒããšã
ãŒã«ïŒïœãã¢ã»ãã³20mlãããªã¡ãã«ãªã³é ž10
mlãããªãžã³ïŒmlãããã³ããªãšãã«ã¢ãã³0.5
mlã«æº¶ããã溶液ã25åéã«ããã€ãŠæ»Žäžããã
ãã®éãåå¿æ¶²ã®æž©åºŠãïŒâãè¶ãã¬ããã«å€éš
ããå·åŽãããããã«30åéïŒâ以äžã§æ¹æãç¶
ããåŸã30mlã®æ°Žã滎äžããã宀枩ã§10åéæ¹æ
ããåŸã200mlã®é£œåé£å¡©æ°Žãšæ°·ãšã®æ··åç©äžã«
æ³šå ¥ããçããçµæ¶ãæ¿Ÿåããããã®çµæ¶ã«ïŒèŠ
å®ã®æ°Žé žåãããªãŠã 氎溶液20mlãå ãPHãçŽ10
ãšãããäžæº¶éšãæ¿ŸåŽããåŸã濟液ããšã¿ããŒã«
150mläžã«æ³šå ¥ããçããçµæ¶ãæ¿Ÿåããšã¿ããŒ
ã«ã§æŽæµããæžå§äžã«ä¹Ÿç¥ããã åéïŒïœãλ0.02N-NaOH nax382nïœ æ¬¡ã«ãæ¬çºæã«ã€ããŠã代衚çãªååç©ã«ã€ã
ãŠãå®æœäŸã«åºã¥ãå ·äœçã«èª¬æãããããããª
ãããæ¬çºæã¯ãäžèšã®å®æœäŸã«ã®ã¿éå®ããã
ãã®ã§ã¯ãªãã å®æœäŸ ïŒ åºè³ªæ¶²ã®èª¿è£œïŒååç©ïŒã®çµæ¶35.05mgã10ml
ã®ã°ãªã·ã³ç·©è¡æ¶²ïŒPH10ã0.5mmolïŒã®å¡©åã
ã°ãã·ãŠã ãå«ãïŒã«æº¶ãããã é µçŽ æ¶²ã®èª¿è£œïŒã·ã°ãã±ãã«ã«ç€Ÿã¢ã«ã«ãªæ§ã
ã¹ãã¢ã¿ãŒãŒTypeIçŽïŒmgã20mlã®èžçæ°Žã«æº¶ã
ãã液ããã³ããã®æ¶²ãïŒåããã³ïŒåã«åžéã
ã液ãïŒçš®é¡èª¿è£œããã æäœïŒåºè³ªæ¶²ïŒmlãè©Šéšç®¡ã«å ¥ã37âã«ïŒåé
å æž©ãããé µçŽ æ¶²0.1mlãå ãã37âã§30åéå
æž©ãåå¿ãããåŸ0.02èŠå®ã®æ°Žé žåãããªãŠã æ°Ž
溶液10mlãå ããŠåå¿ãåæ¢ãããé µçŽ æ¶²ã®ãã
ãã«èžçæ°Žãçšããç¹ãé€ããŠå šãåæ§ã«åŠçã
ãç²æ€æ¶²ãå¯Ÿç §ãšããŠ520nïœã§åžå 床ïŒÎODïŒ
ã枬å®ããããã®ããã«ããŠãæ¿åºŠã®ç°ãªã€ãïŒ
çš®é¡ã®é µçŽ 液ã«ã€ããŠåã 枬å®ãè¡ãªã€ãããã
ããšåãé µçŽ æ¶²ã«ã€ããŠBesseyâLowryæ³ãé©
çšããå Žåã®410nïœã«ãããç²æ€æ¶²ãå¯Ÿç §ãšã
ãåžå 床ïŒÎODïŒã枬å®ããã ãªãBesseyâLowryæ³ã®æäœã¯äžèšååç©ïŒ
ã®çµæ¶35.05mgã®ãããã«ïœâãããããšãã«ãª
ã³é žãããªãŠã 20mgãçšããŠ410nïœã§æ¯è²ãã
ä»ã¯äžèšã®æäœãšå šãåæ§ã§ããã ãããïŒã€ã®æ¹æ³ã«ããÎODã®å€ã®é¢ä¿ã第
ïŒå³ã«ç€ºããã ãã®ç¬¬ïŒå³ãã次ã®ããšãæãããšãªã€ãã (1) é µçŽ æ¿åºŠã«æ¯äŸããŠãããªãã¡Besseyâ
Lowryæ³ã«ããå€ã«æ¯äŸããŠÎODãå€åãã
ã®ã§ÎODã®å€ããé µçŽ ã®æŽ»æ§ãæ±ããããšã
ã§ããã (2) ååç©ïŒãåºè³ªãšããå Žåã®ÎODã¯Bessey
âLowryæ³ã®â³ODãã倧ããªå²åã§å€åããŠ
ããã®ã§ïŒçŽç·ã®åŸé ãïŒä»¥äžïŒãååç©ïŒã
åºè³ªãšããå Žåã®ã»ããBesseyâLowryæ³ã
ãæ床ãé«ãã (3) ååç©ïŒãåºè³ªãšããå Žåã«ã¯520nïœã§æ¯
è²ã§ããã®ã§ã410nïœã§æ¯è²ããBesseyâ
Lowryæ³ãããè¡äžã®è²çŽ ãªã©ã®æè²ç©è³ªã«
ãã劚害ãåãé£ãã ãã®ããã«æ¬çºæã®ååç©ã¯ãã¢ã«ã«ãªæ§ãã¹
ãã¢ã¿ãŒãŒã®å®éçšåºè³ªãšããŠå¥œé©ãªååç©ã§ã
ãããšããããã å®æœäŸ ïŒ å®æœäŸïŒã®ååç©ïŒã®çµæ¶35.05mgã®ãããã«
48.18mgã®ååç©12ã®çµæ¶ãçšããåžå 床ã®æž¬å®
ã520nïœã§ã¯ãªã644nïœã§è¡ãªãä»ã¯å®æœäŸïŒ
ãšåæ§ã®æäœãè¡ãªã€ãå Žåã®çµæã第ïŒå³ã«ç€º
ããããã®ç¬¬ïŒå³ãã次ã®ããšãæããã§ããã (1) é µçŽ æ¿åºŠã«æ¯äŸããŠãããªãã¡Besseyâ
Lowryæ³ã«ããå€ã«æ¯äŸããŠÎODãå€åãã
ã®ã§ÎODã®å€ããé µçŽ ã®æŽ»æ§ãæ±ããããšã
ã§ããã (2) ååç©12ãåºè³ªãšããå Žåã«ã¯644nïœã§æ¯
è²ã§ããã®ã§ã410nïœã§æ¯è²ããBesseyâ
Lowryæ³ããè¡äžã®è²çŽ ãªã©ã®æè²ç©è³ªã«åŠš
害ãåãé£ãã ãã®ããã«æ¬çºæã®ååç©ã¯ãã¢ã«ã«ãªæ§ãã¹
ãã¢ã¿ãŒãŒã®å®éçšåºè³ªãšããŠå¥œé©ãªååç©ã§ã
ãããšããããã
第ïŒå³ããã³ç¬¬ïŒå³ã«ãããŠã暪軞ã¯Bessey
âLowryæ³ãçšããå Žåã®åžå 床ïŒÎODïŒã§ã
ã瞊軞ã¯æ¬çºæã®ååç©ãåºè³ªãšããŠçšããå Žå
ã®åžå 床ïŒÎODïŒã§ããã
âLowryæ³ãçšããå Žåã®åžå 床ïŒÎODïŒã§ã
ã瞊軞ã¯æ¬çºæã®ååç©ãåºè³ªãšããŠçšããå Žå
ã®åžå 床ïŒÎODïŒã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šããããªã³é ž
ãšã¹ãã«ã ïŒåŒäžãïŒã¯æ°ŽçŽ ååããããªãŠã ååãŸãã¯ã«
ãªãŠã ååã§ãããR1ãšR2ã®äžæ¹ã¯ã¡ãã«ã¹ã«
ããã«åºãR1ãšR2ã®ä»æ¹ã¯ãããåºã§ãããR3
ã¯å¡©çŽ ååãŸãã¯æ°ŽçŽ ååãR4ã¯æ°ŽçŽ ååãã
ãããã·ã«åºãã¡ãã«åºãŸãã¯ã¡ãã«ã«ã«ããã«
ã¢ããåºã§ãããR5ã¯æ°ŽçŽ ååãŸãã¯å¡©çŽ åå
ã§ãããR6ã¯ã¡ãã«åºãŸãã¯ïŒâã¹ã«ãã¢ã¢ã€
ã«ããšãã«åºã§ãããïŒ ïŒ äžè¬åŒïŒïŒãŸãã¯ïŒïŒã§è¡šããããªã³é ž
ãšã¹ãã«ãåºè³ªãšããŠçšããããšãç¹åŸŽãšããã¢
ã«ã«ãªæ§ãã¹ãã¢ã¿ãŒãŒã®å®éæ¹æ³ã ïŒåŒäžãïŒã¯æ°ŽçŽ ååããããªãŠã ååãŸãã¯ã«
ãªãŠã ååã§ãããR1ãšR2ã®äžæ¹ã¯ã¡ãã«ã¹ã«
ããã«åºãR1ãšR2ã®ä»æ¹ã¯ãããåºã§ãããR3
ã¯å¡©çŽ ååãŸãã¯æ°ŽçŽ ååãR4ã¯æ°ŽçŽ ååãã
ãããã·ã«åºãã¡ãã«åºãŸãã¯ã¡ãã«ã«ã«ããã«
ã¢ããåºã§ãããR5ã¯æ°ŽçŽ ååãŸãã¯å¡©çŽ åå
ã§ãããR6ã¯ã¡ãã«åºãŸãã¯ïŒâã¹ã«ãã¢ã¢ã€
ã«ããšãã«åºã§ãããïŒ
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56044325A JPS57159499A (en) | 1981-03-26 | 1981-03-26 | Substrate for determining alkaline phosphatase and determining method |
| DE198282102524T DE61731T1 (de) | 1981-03-26 | 1982-03-25 | Phosphorsaeureester und ein verfahren zur quantitativen analyse einer alkalischen phosphatase unter verwendung derselben als substrat. |
| EP82102524A EP0061731B2 (en) | 1981-03-26 | 1982-03-25 | Novel phosphoric ester and a method for quantitative analysis of an alkaline phosphatase using the same as a substrate |
| DE8282102524T DE3273981D1 (en) | 1981-03-26 | 1982-03-25 | Novel phosphoric ester and a method for quantitative analysis of an alkaline phosphatase using the same as a substrate |
| US06/906,098 US4797476A (en) | 1981-03-26 | 1986-09-10 | Mono-4-arylazoaryl phosphoric esters |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56044325A JPS57159499A (en) | 1981-03-26 | 1981-03-26 | Substrate for determining alkaline phosphatase and determining method |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13381591A Division JPH07103134B2 (ja) | 1991-03-29 | 1991-03-29 | ãªã³é žãšã¹ãã« |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57159499A JPS57159499A (en) | 1982-10-01 |
| JPH0215826B2 true JPH0215826B2 (ja) | 1990-04-13 |
Family
ID=12688339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56044325A Granted JPS57159499A (en) | 1981-03-26 | 1981-03-26 | Substrate for determining alkaline phosphatase and determining method |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4797476A (ja) |
| EP (1) | EP0061731B2 (ja) |
| JP (1) | JPS57159499A (ja) |
| DE (2) | DE61731T1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0647624A (ja) * | 1992-07-30 | 1994-02-22 | Mitsubishi Electric Corp | æŸé»å å·¥è£ çœ® |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3732871A1 (de) * | 1987-09-30 | 1989-04-20 | Behringwerke Ag | Chromogene substrate |
| JPH0731201B2 (ja) * | 1987-12-31 | 1995-04-10 | ããããã¯ã¹ã»ã€ã³ã³ãŒãã¬ãŒããã | ååŠçºå ã«ãã枬å®æ³ |
| DE4406665A1 (de) * | 1994-03-01 | 1995-09-07 | Biosynth Ag | Enzymsubstrate mit 2-(2-Thiazolylazo)-p-kresol als chromogener Gruppe |
| WO2015124703A1 (en) * | 2014-02-24 | 2015-08-27 | Ventana Medical Systems, Inc. | Quinone methide analog signal amplification |
| JP2016084421A (ja) * | 2014-10-27 | 2016-05-19 | å¯å£«ãã€ã«ã æ ªåŒäŒç€Ÿ | ã¢ãŸè²çŽ ã®ã¢ã«ã«ãªéå±å¡©ãã¢ã«ã«ãªåé¡éå±å¡©åã³ãã®äºå€ç°æ§äœãçè²çµæç©ãæè²æ¹æ³åã³æè²ç© |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL102448C (ja) * | 1956-11-07 | |||
| US2959582A (en) * | 1957-07-26 | 1960-11-08 | Hoechst Ag | Azodyestuffs soluble in water |
| US4051240A (en) * | 1972-07-07 | 1977-09-27 | Ciba-Geigy Corporation | O,s-dialkyl-o-(4-phenylazophenyl)-thiophosphates and pesticidal compositions thereof |
| FR2206358B1 (ja) * | 1972-11-13 | 1975-11-07 | Ugine Kuhlmann | |
| US3975405A (en) * | 1974-08-01 | 1976-08-17 | Coulter Diagnostics, Inc. | Monophosphate salt of o-cresolphthalein |
| US4052381A (en) * | 1975-04-21 | 1977-10-04 | American Cyanamid Company | Substituted phosphorothioic acid and method of use in siphonaptera compositions in warm-blooded animals |
| SU853536A1 (ru) * | 1979-08-20 | 1981-08-07 | ÐÐœÑÑОÑÑÑ ÐÐžÐŸÑ ÐžÐŒÐžÐž ÐÐœ ÐОÑПвÑкПй СÑÑÑ | СÑбÑÑÑÐ°Ñ ÑелПÑМПй ÑПÑÑаÑÐ°Ð·Ñ |
-
1981
- 1981-03-26 JP JP56044325A patent/JPS57159499A/ja active Granted
-
1982
- 1982-03-25 EP EP82102524A patent/EP0061731B2/en not_active Expired - Lifetime
- 1982-03-25 DE DE198282102524T patent/DE61731T1/de active Pending
- 1982-03-25 DE DE8282102524T patent/DE3273981D1/de not_active Expired
-
1986
- 1986-09-10 US US06/906,098 patent/US4797476A/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0647624A (ja) * | 1992-07-30 | 1994-02-22 | Mitsubishi Electric Corp | æŸé»å å·¥è£ çœ® |
Also Published As
| Publication number | Publication date |
|---|---|
| DE61731T1 (de) | 1983-11-24 |
| DE3273981D1 (en) | 1986-12-04 |
| JPS57159499A (en) | 1982-10-01 |
| EP0061731A2 (en) | 1982-10-06 |
| EP0061731B2 (en) | 1992-01-29 |
| US4797476A (en) | 1989-01-10 |
| EP0061731A3 (en) | 1983-03-16 |
| EP0061731B1 (en) | 1986-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2235977T3 (es) | Analogos de 8-(anilino)-1-naftalenosulfonato y su uso en ensayos de deteccion de analitos. | |
| US4336331A (en) | Method for assaying the activity of γ-glutamyl transpeptidase in serum | |
| JPS62215399A (ja) | å æ°Žå解å¯èœãªååç©äžŠã³ã«ãããå«ãåæçµæç©åã³åæçŽ å䞊ã³ã«ãããçšããåææ¹æ³ | |
| CA2335564A1 (en) | Novel polycyclic aromatic fluorogenic substrates for hydrolases | |
| JPH0215826B2 (ja) | ||
| JP2675835B2 (ja) | è²çŽ ååºè³ª | |
| JP3312793B2 (ja) | ã¢ãªãŒã«ã¢ãŸã¯ãã¢ã€ãªããã©ã¢ããã³ãããçšããã«ã«ã·ãŠã ã€ãªã³ã®æž¬å®æ¹æ³ | |
| JPH0733789A (ja) | ãªã³é žãšã¹ãã« | |
| US5254677A (en) | β-galactosidase substrates for cedia | |
| JPH01160990A (ja) | ïŒâããããŒã«ãã¿ã¬ã€ã³ã¢ããã¹ããšãŒãããã®è£œæ³ãã¢ã«ã«ãªãã¹ãã¢ã¿ãŒãŒã®æž¬å®æ³åã³ã¢ã«ã«ãªãã¹ãã¢ã¿ãŒãŒæ€åºçšèšºæå€ | |
| US4933277A (en) | Method of quantitative analysis of hydrogen peroxide and reagent therefor | |
| JPS63216499A (ja) | ãã¹ãã¢ã¿âãŒæŽ»æ§æž¬å®æ¹æ³ | |
| US5081274A (en) | 4-acyl-2,6-dihalophenyl-phosphoric acid derivatives useful in the determination of acid phosphatase activity | |
| US4822891A (en) | 4-amino-2,3-di-substituted-1-(mono- or trichlorophenyl)-3-pyrazolin-5-ones | |
| JPS6131096B2 (ja) | ||
| JPS5913199B2 (ja) | ã¢ãã©âãŒæŽ»æ§æž¬å®æ³ | |
| JPH07247292A (ja) | çºè²æ§ååç© | |
| JPH0730107B2 (ja) | å æ°Žåè§£é µçŽ æŽ»æ§ãæããç©è³ªã®æ€åºæ¹æ³åã³äºç°åŒååç© | |
| JPH01216964A (ja) | æ°èŠã³ãªã³èªå°äœåã³ãããçšããè¡æž ã³ãªã³ãšã¹ãã©ãŒãŒæŽ»æ§æž¬å®æ³ | |
| US5227291A (en) | Method for determination of acid phosphatase activity using 4-acyl-2, 6-dihalophenyl phosphoric acid derivatives | |
| JPH02180892A (ja) | æ°èŠãªã³é žèªå°äœåã³ãããçšããé žæ§ãã¹ãã¡ã¿ãŒãŒæŽ»æ§æž¬å®æ³ | |
| JP4004095B2 (ja) | æ°èŠåºè³ªååç©åã³ã³ãªã³ãšã¹ãã©ãŒãŒæŽ»æ§æž¬å®æ¹æ³ | |
| JPS60238000A (ja) | æ°èŠãªã³ãªã³ãšã¹ãã©âãŒæŽ»æ§æž¬å®æ³ | |
| JPS603838B2 (ja) | ã³ãªã³ãšã¹ãã©âãŒã®æŽ»æ§æž¬å®æ³ | |
| JPS5930699B2 (ja) | æ°èŠã¢ãŸãã³ãžã«ã¢ãã³ååç©ã®è£œé æ³ |